Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4786196
Max Phase: Preclinical
Molecular Formula: C44H78N18O11
Molecular Weight: 1035.22
Molecule Type: Unknown
Associated Items:
ID: ALA4786196
Max Phase: Preclinical
Molecular Formula: C44H78N18O11
Molecular Weight: 1035.22
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](O)CN)C(=O)NCC(=O)N[C@H](CC[C@@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N/C(=C\CCNC(=N)N)C(=O)O
Standard InChI: InChI=1S/C44H78N18O11/c1-24(48)13-14-29(57-34(64)22-54-36(65)25(2)56-41(70)35(33(63)20-47)61-37(66)27(49)9-3-5-15-45)42(71)62-18-8-12-32(62)40(69)60-31(19-26-21-52-23-55-26)39(68)58-28(10-4-6-16-46)38(67)59-30(43(72)73)11-7-17-53-44(50)51/h11,21,23-25,27-29,31-33,35,63H,3-10,12-20,22,45-49H2,1-2H3,(H,52,55)(H,54,65)(H,56,70)(H,57,64)(H,58,68)(H,59,67)(H,60,69)(H,61,66)(H,72,73)(H4,50,51,53)/b30-11-/t24-,25+,27+,28+,29-,31+,32+,33+,35+/m1/s1
Standard InChI Key: LPSYVDLVOJKQBO-MLPYPHLGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1035.22 | Molecular Weight (Monoisotopic): 1034.6097 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Loza E,Sarciaux M,Ikaunieks M,Katkevics M,Kukosha T,Trufilkina N,Ryabova V,Shubin K,Pantel L,Serri M,Huseby DL,Cao S,Yadav K,Hjort K,Hughes D,Gualtieri M,Suna E,Racine E. (2020) Structure-activity relationship studies on the inhibition of the bacterial translation of novel Odilorhabdins analogues., 28 (11): [PMID:32279921] [10.1016/j.bmc.2020.115469] |
Source(1):